| A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered … BL Ellis, ML Hirsch, JC Barker, JP Connelly, RJ Steininger, MH Porteus Virology journal 10, 1-10, 2013 | 255 | 2013 |
| Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs BL Ellis, ML Hirsch, SN Porter, RJ Samulski, MH Porteus Gene therapy 20 (1), 35-42, 2013 | 122 | 2013 |
| An extensive comparison of the effect of anthelmintic classes on diverse nematodes Y Hu, BL Ellis, YY Yiu, MM Miller, JF Urban, LZ Shi, RV Aroian PloS one 8 (7), e70702, 2013 | 112 | 2013 |
| Creating higher titer lentivirus with caffeine BL Ellis, PR Potts, MH Porteus Human gene therapy 22 (1), 93-100, 2011 | 69 | 2011 |
| Nitazoxanide: nematicidal mode of action and drug combination studies VS Somvanshi, BL Ellis, Y Hu, RV Aroian Molecular and biochemical parasitology 193 (1), 1-8, 2014 | 52 | 2014 |
| Bacillus subtilis strain engineered for treatment of soil-transmitted helminth diseases Y Hu, MM Miller, AI Derman, BL Ellis, RG Monnerat, J Pogliano, ... Applied and environmental microbiology 79 (18), 5527-5532, 2013 | 39 | 2013 |
| Using a health-rating system to evaluate the usefulness of Caenorhabditis elegans as a model for anthelmintic study KJ Weaver, CJ May, BL Ellis PLoS One 12 (6), e0179376, 2017 | 20 | 2017 |
| Improving Viral Vectors for Gene Targeting in Gene Therapy BL Ellis | | 2011 |
